BRAIN FDG PET/CT SCAN  

DATE: 11/17/2005

PROCEDURE:  Following IV injection of 18-fluoro-2-deoxyglucose (FDG) and a standard uptake period, the patient was imaged on a CTI PET/CT (CTI Reveal) scanner.  After CT images were acquired for photon attenuation correction a 15-minute static acquisition of the brain was obtained.  Multiple axial images were obtained and sagittal and coronal reconstructions were performed.  Images were reviewed in the multimodality mode.  

FDG DOSE: [10] mCi

CORRELATIVE STUDIES: None

COMPARISON: None

CLINICAL HISTORY: The patient is a [...]-year-old [fe]male with past medical history significant for [...], who is referred for evaluation of [...].

FINDINGS: 

Normal tracer uptake is seen in the cortex, cerebellum, and deep structures of the brain.

The brain structures including the cortex, the basal ganglia the brainstem and the cerebellum show normal and symmetric tracer uptake. There is no evidence for prominence of the sensory motor strips or of the visual cortex. The cingulate gyrus shows homogeneous tracer uptake when compared to the remainder of the cerebral cortex.

CONCLUSIONS:

Normal glucose metabolism of the brain.

No evidence for a progressive neurodegenerative disorder, such as Alzheimer's disease. 

In comparison to the prior study there is no appreciable change.

Thank you for referring this patient to the UCLA Nuclear Medicine Clinic.

I, [...], M.D., Ph.D., have reviewed this Nuclear Medicine study personally, and am in full agreement with the findings of the report presented here.